APOTHEEK CALLENS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
APOTHEEK CALLENS
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€13,752
2024 · €33,588-€19,836
Equity
€285,640
2024 · €273,979+€11,661
Cash
€50,030
2024 · €45,911+€4,119
Balance sheet total
€928,180
2024 · €523,266+€404,914
Largest movements
Assets
- Tangible fixed assets +€387,238
up €387,238 (+123%), from €315,164 to €702,403
of which Land and buildings: +€378,323
- Deferred charges and accrued income +€16,706
up €16,706 (+39.4%), from €42,409 to €59,115
Equity and liabilities
- Debts after one year +€314,200
up €314,200 (+163%), from €192,336 to €506,536
- Trade debts +€38,881
up €38,881 (+139%), from €27,905 to €66,786
- Current portion of long-term debt +€35,460
up €35,460 (+194%), from €18,314 to €53,774
- Reserves +€12,086
up €12,086 (+4.9%), from €245,477 to €257,562
Income statement
- Gross operating margin -€12,554
down €12,554 (-15.5%), from €80,908 to €68,354
- Taxes -€11,035
down €11,035 (-87.6%), from €12,597 to €1,562
- Financial charges +€10,486
up €10,486 (+104%), from €10,041 to €20,527
- Depreciation +€7,320
up €7,320 (+31.1%), from €23,554 to €30,874
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€33,588
Gross operating margin
-€12,554
Depreciation
-€7,320
Other operating charges
-€117
Financial income
-€395
Financial charges
-€10,486
Taxes
+€11,035
Result 2025
€13,752
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€72,980
Investment
-€418,112
Financing
+€349,252
Cash 2024
€45,911
From operations (derived)
+€72,980
Net result for the year
+€13,752
Depreciation
+€30,874
Stocks and contracts
+€1,180
Receivables within one year
+€1,970
Deferred charges and accrued income
-€16,706
Smaller working-capital items
+€154
Trade debts
+€38,881
Other debts
+€2,875
Investment (derived)
-€418,112
Investment in fixed assets (net)
-€418,112
Financing
+€349,252
Debts after one year
+€314,200
Current portion of long-term debt
+€35,460
Short-term financial debts
+€1,683
Contributions, distributions and other
-€2,090
Cash 2025
€50,030
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €523,266 | €928,180 | +€404,914 | +77.4% |
| Fixed assets | 21/28 | €315,216 | €702,454 | +€387,238 | +123% |
| Tangible fixed assets | 22/27 | €315,164 | €702,403 | +€387,238 | +123% |
| Land and buildings | 22 | €311,590 | €689,913 | +€378,323 | +121% |
| Plant, machinery and equipment | 23 | - | €2,643 | +€2,643 | |
| Furniture and vehicles | 24 | €3,574 | €9,847 | +€6,272 | +175% |
| Financial fixed assets | 28 | €51 | €51 | = | 0.0% |
| Current assets | 29/58 | €208,051 | €225,726 | +€17,676 | +8.5% |
| Stocks and contracts in progress | 3 | €95,011 | €93,830 | -€1,180 | -1.2% |
| Stocks | 30/36 | €95,011 | €93,830 | -€1,180 | -1.2% |
| Amounts receivable within one year | 40/41 | €24,721 | €22,751 | -€1,970 | -8.0% |
| Trade receivables | 40 | €15,981 | €16,690 | +€709 | +4.4% |
| Other amounts receivable | 41 | €8,739 | €6,061 | -€2,679 | -30.7% |
| Cash at bank and in hand | 54/58 | €45,911 | €50,030 | +€4,119 | +9.0% |
| Deferred charges and accrued income | 490/1 | €42,409 | €59,115 | +€16,706 | +39.4% |
| Total equity and liabilities | 10/49 | €523,266 | €928,180 | +€404,914 | +77.4% |
| Equity | 10/15 | €273,979 | €285,640 | +€11,661 | +4.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €245,477 | €257,562 | +€12,086 | +4.9% |
| Distributable reserves | 133 | €245,477 | €257,562 | +€12,086 | +4.9% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Investment grants | 15 | €9,902 | €9,478 | -€424 | -4.3% |
| Provisions and deferred taxes | 16 | €2,476 | €2,369 | -€106 | -4.3% |
| Deferred taxes | 168 | €2,476 | €2,369 | -€106 | -4.3% |
| Amounts payable | 17/49 | €246,812 | €640,171 | +€393,359 | +159% |
| Amounts payable after more than one year | 17 | €192,336 | €506,536 | +€314,200 | +163% |
| Financial debts | 170/4 | €192,336 | €506,536 | +€314,200 | +163% |
| Amounts payable within one year | 42/48 | €54,175 | €133,635 | +€79,460 | +147% |
| Current portion of amounts payable after more than one year | 42 | €18,314 | €53,774 | +€35,460 | +194% |
| Financial debts | 43 | - | €1,683 | +€1,683 | |
| Credit institutions | 430/8 | - | €1,683 | +€1,683 | |
| Trade debts | 44 | €27,905 | €66,786 | +€38,881 | +139% |
| Suppliers | 440/4 | €27,905 | €66,786 | +€38,881 | +139% |
| Taxes, remuneration and social security | 45 | €2,977 | €3,539 | +€562 | +18.9% |
| Taxes | 450/3 | €2,977 | €3,539 | +€562 | +18.9% |
| Other amounts payable | 47/48 | €4,978 | €7,853 | +€2,875 | +57.8% |
| Accrued charges and deferred income | 492/3 | €301 | €0 | -€301 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €23,554 | €30,874 | +€7,320 | +31.1% |
| Other operating charges | 640/8 | €2,796 | €2,913 | +€117 | +4.2% |
| Gross operating margin | 9900 | €80,908 | €68,354 | -€12,554 | -15.5% |
| Operating profit (loss) | 9901 | €54,558 | €34,567 | -€19,991 | -36.6% |
| Financial income | 75/76B | €1,562 | €1,167 | -€395 | -25.3% |
| Recurring financial income | 75 | €1,562 | €1,167 | -€395 | -25.3% |
| Financial charges | 65/66B | €10,041 | €20,527 | +€10,486 | +104% |
| Recurring financial charges | 65 | €10,041 | €20,527 | +€10,486 | +104% |
| Profit (loss) for the period before taxes | 9903 | €46,079 | €15,207 | -€30,872 | -67.0% |
| Transfer from deferred taxes | 780 | €106 | €106 | = | 0.0% |
| Income taxes | 67/77 | €12,597 | €1,562 | -€11,035 | -87.6% |
| Profit (loss) for the period | 9904 | €33,588 | €13,752 | -€19,836 | -59.1% |
| Profit (loss) for the period to be appropriated | 9905 | €33,588 | €13,752 | -€19,836 | -59.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.